Jose-Alberto Palma

Every year, millions of people face life-threatening illnesses for which effective treatments are limited or nonexistent. Yet only a small fraction of patients participates in clinical trials, even though these studies are vital to developing new therapies. Fewer than 8 percent of adult cancer patients take part in these trials, with even lower rates among Black and Hispanic populations. This...